|
1
|
Kahner BN, Shankar H, Murugappan S, Prasad
GL and Kunapuli SP: Nucleotide receptor signaling in platelets. J
Thromb Haemost. 4:2317–2326. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li Z, Delaney MK, O’Brien KA and Du X:
Signaling during platelet adhesion and activation. Arterioscler
Thromb Vasc Biol. 30:2341–2349. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dangelmaier C, Jin J, Daniel JL, Smith JB
and Kunapuli SP: The P2Y1 receptor mediates ADP-induced p38
kinase-activating factor generation in human platelets. Eur J
Biochem. 267:2283–2289. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Falker K, Lange D and Presek P: ADP
secretion and subsequent P2Y12 receptor signalling play a crucial
role in thrombin-induced ERK2 activation in human platelets. Thromb
Haemost. 92:114–123. 2004.PubMed/NCBI
|
|
5
|
Stegner D and Nieswandt B: Platelet
receptor signaling in thrombus formation. J Mol Med (Berl).
89:109–121. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mymrikov EV, Seit-Nebi AS and Gusev NB:
Large potentials of small heat shock proteins. Physiol Rev.
91:1123–1159. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhu Y, O’Neill S, Saklatvala J, Tassi L
and Mendelsohn ME: Phosphorylated HSP27 associates with the
activation-dependent cytoskeleton in human platelets. Blood.
84:3715–3723. 1994.PubMed/NCBI
|
|
8
|
Kato H, Takai S, Matsushima-Nishiwaki R,
Adachi S, Minamitani C, Otsuka T, Tokuda H, Akamatsu S, Doi T,
Ogura S and Kozawa O: HSP27 phosphorylation is correlated with
ADP-induced platelet granule secretion. Arch Biochem Biophys.
475:80–86. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ellis MH, Avraham H and Groopman JE: The
regulation of megakaryocytopoiesis. Blood Rev. 9:1–6. 1995.
View Article : Google Scholar
|
|
10
|
Ezumi Y, Takayama H and Okuma M:
Thrombopoietin, c-Mpl ligand, induces tyrosine phosphorylation of
Tyk2, JAK2, and STAT3, and enhances agonists-induced aggregation in
platelets in vitro. FEBS Lett. 374:48–52. 1995. View Article : Google Scholar
|
|
11
|
Kojima H, Hamazaki Y, Nagata Y, Todokoro
K, Nagasawa T and Abe T: Modulation of platelet activation in vitro
by thrombopoietin. Thromb Haemost. 74:1541–1545. 1995.PubMed/NCBI
|
|
12
|
Rodriguez-Linares B and Watson SP:
Thrombopoietin potentiates activation of human platelets in
association with JAK2 and TYK2 phosphorylation. Biochem J.
316:93–98. 1996.PubMed/NCBI
|
|
13
|
Kubota Y, Arai T, Tanaka T, Yamaoka G,
Kiuchi H, Kajikawa T, Kawanishi K, Ohnishi H, Yamachi M, Takahara J
and Iriono S: Thrombopoietin modulates platelet activation in vitro
through protein-tyrosine phosphorylation. Stem Cells. 14:439–444.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ezumi Y, Nishida E, Uchiyama T and
Takayama H: Thrombopoietin potentiates agonist-stimulated
activation of p38 mitogen-activated protein kinase in human
platelets. Biochem Biophys Res Commun. 261:58–63. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kojima H, Shinagawa A, Shimizu S, Kanada
H, Hibi M, Hirano T and Nagasawa T: Role of phosphatidylinositol-3
kinase and its association with Gab1 in thrombopoietin-mediated
up-regulation of platelet function. Exp Hematol. 29:616–622. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen J, Herceg-Harjacek L, Groopman JE and
Grabarek J: Regulation of platelet activation in vitro by the c-Mpl
ligand, thrombopoietin. Blood. 86:4054–4062. 1995.PubMed/NCBI
|
|
17
|
Oda A, Miyakawa Y, Druker BJ, Ozaki K,
Yabusaki K, Shirasawa Y, Handa M, Kato T, Miyazaki H, Shimosaka A
and Ikeda Y: Thrombopoietin primes human platelet aggregation
induced by shear stress and by multiple agonists. Blood.
87:4664–4670. 1996.PubMed/NCBI
|
|
18
|
Eilers M, Schulze H, Welte K and Ballmaier
M: Thrombopoietin acts synergistically on Ca(2+) mobilization in
platelets caused by ADP or thrombin receptor agonist peptide.
Biochem Biophys Res Commun. 263:230–238. 1999.
|
|
19
|
Laemmli UK: Cleavage of structural
proteins during the assembly of the head of bacteriophage T4.
Nature. 227:680–685. 1970. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wun T, Paglieroni T, Hammond WP,
Kaushansky K and Foster DC: Thrombopoietin is synergistic with
other hematopoietic growth factors and physiologic platelet
agonists for platelet activation in vitro. Am J Hematol.
54:225–232. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Henn V, Slupsky JR, Grafe M,
Anagnostopoulos I, Forster R, Muller-Berghaus G and Kroczek RA: D40
ligand on activated platelets triggers an inflammatory reaction of
endothelial cells. Nature. 391:591–594. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Heeschen C, Dimmeler S, Hamm CW, van den
Brand MJ, Boersma E, Zeiher AM and Simooms ML: Soluble CD40 ligand
in acute coronary syndromes. N Engl J Med. 348:1104–1111. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Inwald DP, McDowall A, Peters MJ, Callard
RE and Klein NJ: CD40 is constitutively expressed on platelets and
provides a novel mechanism for platelet activation. Circ Res.
92:1041–1048. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kaushansky K: Thrombopoietin. N Engl J
Med. 339:746–754. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zakynthinos SG, Papanikolaou S,
Theodoridis T, Zakynthinos EG, Christopoulou-Kokkinou V, Katsaris G
and Mavrommatis AC: Sepsis severity is the major determinant of
circulating thrombopoietin levels in septic patients. Crit Care
Med. 32:1004–1010. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lupia E, Bosco O, Mariano F, Dondi AE,
Goffi A, Spatola T, Cuccurullo A, Tizzani P, Brondino G, Stella M
and Montrucchio G: Elevated thrombopoietin in plasma of burned
patients without and with sepsis enhances platelet activation. J
Thromb Haemost. 7:1000–1008. 2009. View Article : Google Scholar : PubMed/NCBI
|
